BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28064372)

  • 1. Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.
    Hedderich DM; Hasenberg T; Haneder S; Schoenberg SO; Kücükoglu Ö; Canbay A; Otto M
    Obes Surg; 2017 Jul; 27(7):1755-1762. PubMed ID: 28064372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study.
    Li M; Cao D; Liu Y; Jin L; Zeng N; Wang L; Zhao K; Lv H; Zhang M; Zhang P; Yang Z; Zhang Z
    Obes Surg; 2020 May; 30(5):1917-1928. PubMed ID: 32048152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
    Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
    Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How bariatric surgery affects liver volume and fat density in NAFLD patients.
    Luo RB; Suzuki T; Hooker JC; Covarrubias Y; Schlein A; Liu S; Schwimmer JB; Reeder SB; Funk LM; Greenberg JA; Campos GM; Sandler BJ; Horgan S; Sirlin CB; Jacobsen GR
    Surg Endosc; 2018 Apr; 32(4):1675-1682. PubMed ID: 29218660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI.
    Hui SCN; Wong SKH; Ai Q; Yeung DKW; Ng EKW; Chu WCW
    Eur Radiol; 2019 Feb; 29(2):849-856. PubMed ID: 30062524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
    Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
    Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort.
    Koh ZJ; Salgaonkar HP; Lee WJJ; Kim GW; Tan CH; Cheng A; Lomanto D; So JBY; Dan YY; Shabbir A
    Obes Surg; 2019 Mar; 29(3):862-868. PubMed ID: 30515622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.
    Algooneh A; Almazeedi S; Al-Sabah S; Ahmed M; Othman F
    Surg Endosc; 2016 May; 30(5):1983-7. PubMed ID: 26194256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study.
    de Freitas Diniz TB; de Jesus RN; Jimenez LS; Pareja JC; Chaim EA; Cazzo E
    Obes Surg; 2020 Feb; 30(2):456-460. PubMed ID: 31529394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?
    Goldoni MB; Fontes PRO; GuimarÃes MM; Diedrich-Neto JA; Nogueira T; Teixeira UF; Giacomazzi CB; Kiss G; Pioner SR; Rodrigues PD
    Arq Bras Cir Dig; 2021; 33(3):e1549. PubMed ID: 33470379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study.
    Elhelw O; Ragavan S; Majeed W; Alkhaffaf B; Mohammed N; Senapati S; Ammori BJ; Robinson JA; Syed AA
    Surgeon; 2024 Feb; 22(1):e26-e33. PubMed ID: 37567846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery].
    Silvestre V; Ruano M; García-Lescún MC; Aguirregoicoa E; Criado L; Rodríguez A; Marco A; García-Blanch G
    Nutr Hosp; 2007; 22(5):602-6. PubMed ID: 17970546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.
    Perysinakis I; Pappis HC; Margaris E
    Obes Surg; 2019 Mar; 29(3):1058-1067. PubMed ID: 30617917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.